logo-loader
viewHeritage Cannabis Holdings Corp.

Heritage Cannabis sign deal to work with Canntab Therapeutics

Heritage Cannabis (CSE:CANN) President and CEO Clint Sharples and Canntab Therapeutics (CSE:PILL) CFO Richard Goldstein joined Christine Corrado from Proactive Investors New York to talk about their partnership that seems to really benefit both companies.

Heritage’s subsidiary Purefarma Solutions will provide
processing services for hemp supplied by Canntab, to their specification, as required for the production of Canntab’s planned ingestible oral cannabis products.

Quick facts: Heritage Cannabis Holdings Corp.

Price: 0.235 CAD

CSE:CANN
Market: CSE
Market Cap: $111.3 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Heritage Cannabis Holdings Corp. named herein, including the promotion by the Company of Heritage Cannabis Holdings Corp. in any Content on the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Heritage Cannabis expands relationship with Zenabis Global

Heritage Cannabis (CSE: CANN) President and CEO Clint Sharples joined Steve Darling from Proactive in Toronto with news the company is expanding their relationship with Zenabis Global. That allows Heritage to have the right of first offer to acquire high-quality trim cultivated by Zenabis, which...

1 week, 4 days ago

2 min read